Johnson &Amp; Johnson Layoffs 2024. Johnson and johnson's pharmaceutical arm is quietly undergoing a full overhaul, discontinuing numerous programs and cutting jobs across the globe. For fiscal 2024, johnson & johnson now expects adjusted earnings per share of $9.88 to $9.98, lower than previously expected $9.97 to $10.07.

Intends to eliminate hundreds of positions in new jersey, according to the state’s warn notice archive. The largest and most broadly based healthcare company in the world, johnson & johnson company has said that it will cut some jobs due to inflationary pressure and.